Holen Sie sich die Stockscreener-App
0.2497
11.18%
0.0251
Vorhandelsmarkt:
.25
0.0003
+0.12%
Schlusskurs vom Vortag:
$0.2246
Offen:
$0.2288
24-Stunden-Volumen:
8.83M
Relative Volume:
0.53
Marktkapitalisierung:
$2.97M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-11.53M
KGV:
-0.0518
EPS:
-4.82
Netto-Cashflow:
$-11.12M
1W Leistung:
+21.57%
1M Leistung:
-21.99%
6M Leistung:
-64.38%
1J Leistung:
-84.77%
1-Tages-Spanne:
$0.222
$0.2689
1-Wochen-Bereich:
$0.20
$0.2689
52-Wochen-Spanne:
$0.15
$3.10
Processa Pharmaceuticals Inc Stock (PCSA) Company Profile
Firmenname
Processa Pharmaceuticals Inc
Sektor
Branche
Telefon
443-776-3133
Adresse
7380 COCA COLA DRIVE, HANOVER
Vergleichen Sie PCSA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PCSA
Processa Pharmaceuticals Inc
|
0.2497 | 5.38M | 0 | -11.53M | -11.12M | -4.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Processa Pharmaceuticals Inc Stock (PCSA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-25 | Eingeleitet | H.C. Wainwright | Buy |
Processa Pharmaceuticals Inc Aktie (PCSA) Neueste Nachrichten
Processa Pharmaceuticals Inc. Stock Analysis and ForecastRecord-breaking capital gains - jammulinksnews.com
Processa Pharmaceuticals Inc (PCSA) Stock: A Year of Stock Market Dynamics - investchronicle.com
What drives Processa Pharmaceuticals Inc. stock priceUnbelievable profit margins - jammulinksnews.com
What makes Processa Pharmaceuticals Inc. stock price move sharplyFree Wealth-Building Investment Strategies - Newser
What analysts say about Processa Pharmaceuticals Inc. stockRapid growth trajectories - Autocar Professional
Is Processa Pharmaceuticals Inc. a good long term investmentRecord-breaking gains - Autocar Professional
Processa Pharmaceuticals Approves Key Proposals at Annual Meeting - The Globe and Mail
RedChip Showcases Processa Pharmaceuticals and BullFrog AI on Bloomberg TV - AInvest
Processa Pharmaceuticals and BullFrog AI Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Des Moines Register
The Convergence of AI and Biotech: BullFrog AI and Processa Pharmaceuticals as Catalysts for Disruption - AInvest
How Processa Pharmaceuticals Inc. stock performs during market volatilityTrend Following Trades - Newser
Why Processa Pharmaceuticals Inc. stock attracts strong analyst attentionCarefully Curated High Return Stocks - Newser
Processa Pharmaceuticals Reschedules Annual Shareholder Meeting - TipRanks
Processa Pharmaceuticals to reconvene annual meeting after achieving quorum By Investing.com - Investing.com South Africa
Processa Pharmaceuticals to reconvene annual meeting after achieving quorum - Investing.com
Processa Pharmaceuticals, Inc. (PCSA) Secures Buy Rating on Portfolio Progress - MSN
Processa Pharmaceuticals: Betting on Catalyst-Driven Value Acceleration - AInvest
Processa Stock Soars 33.96% on Penny Stock Inclusion - AInvest
Processa Stock Soars 14.62% on Penny Stock Inclusion - AInvest
12 Best Fundamentally Strong Penny Stocks to Invest in - Insider Monkey
HC Wainwright Has Positive Estimate for Heatwurx Q2 Earnings - Defense World
Processa terminates license agreement for PCS3117 - TipRanks
Processa Pharmaceuticals adjourns annual meeting due to lack of quorum By Investing.com - Investing.com UK
Processa Pharmaceuticals adjourns annual meeting due to lack of quorum - Investing.com
Processa Pharmaceuticals Adjourns Annual Shareholder Meeting - TipRanks
Processa Pharmaceuticals Plunges 15.31% Amid Market Volatility - AInvest
Rx Rundown: Sanofi, Processa Pharmaceuticals, Eli Lilly and more - Medical Marketing and Media
Processa Pharmaceuticals Announces Public Offering Pricing - TipRanks
Processa inks licensing deal with Intact for gastroparesis drug By Investing.com - Investing.com India
Processa Pharmaceuticals Announces Pricing of $7 Million Public Offering - The Manila Times
Processa Pharmaceuticals (PCSA) Sets Public Offering Price at $0 - GuruFocus
Processa Pharmaceuticals Signs Binding Term Sheet Granting - GlobeNewswire
Finanzdaten der Processa Pharmaceuticals Inc-Aktie (PCSA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):